TITLE

"New approach" as Health Canada seeks conditional licences for drugs, new pediatric office

AUTHOR(S)
Eggertson, Laura
PUB. DATE
March 2005
SOURCE
CMAJ: Canadian Medical Association Journal;3/29/2005, Vol. 172 Issue 7, p864
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Focuses on the plans of Canadian Health Minister Ujjal Dosanjh to improve drug approval system which includes conditional licensing for some drugs and the creation of a pediatric office to asses prescription drugs for children. Health budget for drug safety and speeding up drug review; Requirement for Health Canada to grant conditional drug approvals or licenses to pharmaceutical companies; Justification of Health Canada to their refusal to release information about deliberations to approve or withdraw drugs.
ACCESSION #
16457543

 

Related Articles

  • Minister announces new drug approval initiatives.  // HIV/AIDS Policy & Law Review;Aug2005, Vol. 10 Issue 2, p21 

    The article informs that Health Minister Ujjal Dosanjh says that he wants to revamp Canada's drug approval system. His plans include a more open and transparent approach to drug approvals, and conditional licensing for some drugs. In an interview with the "Canadian Medical Association Journal,"...

  • Health Canada to seek public input on drugs. Eggertson, Laura // CMAJ: Canadian Medical Association Journal;3/15/2005, Vol. 172 Issue 6, p733 

    Reports on Canadian Health Minister Ujjal Dosanjh's proposed changes to the country's drug approval process. Reason behind the changes in the drug approval process; Information on the Drug Safety Oversight Board created by the U.S. Food & Drug Administration; Reaction of the Canadian Health...

  • Health Canada shifts focus on drug regulation.  // PharmacoEconomics & Outcomes News;8/11/2007, Issue 534, p2 

    The article deals with the Progressive Licensing Framework, a modernization project from Health Canada that will change the way drugs are assessed in Canada. The project addresses the need for increased postmarketing surveillance and takes into account the accumulation of data over a drug's...

  • FEDS DENY ACCESS TO AIDS THERAPY. Boyce, Douglas // Xtra (Toronto);12/22/2005, Issue 552, p14 

    Reports on the decision of the Health Canada to deny access of Paul Lewand, chairman of British Columbia Persons With AIDS Society, to his AIDS drug treatment. Participation of Svend Robinson, Democratic Party candidate for Vancouver Centre, in the effort to overturn the decision of the Health...

  • Health Canada shifts focus on drug regulation.  // Reactions Weekly;8/4/2007, Issue 1163, p1 

    The article reports on the Progressive Licensing Framework, the modernization project of Health Canada governing drug approval and monitoring processes. The Progressive Licensing Framework has four essential components. This could result to a change in the regulatory standards of Canada in the...

  • Health Canada drug approval process slower than in Europe and US.  // British Columbia Medical Journal;Jun2013, Vol. 55 Issue 5, p234 

    The article deals with a report the Fraser Institute which revealed that the drug approval process by Health Canada takes nearly a year which is slower than in Europe and the U.S.

  • Getting the goods on health product safety. Fletcher, Marla // Canadian Nurse;Oct2005, Vol. 101 Issue 8, p10 

    Reports on the launching of the MedEffect information resource by Health Canada in August 2005. Purpose of the campaign; Remarks from Health Minister Ujjal Dosanjh on the significance of MedEffect.

  • Approving New Medicines in Canada: Health Canada Needs a Dose of Competition. Graham, John R. // Fraser Forum;Jun2005, p9 

    Explores the drug approval process involved in the introduction of new drugs in Canada. Likelihood for Health Canada to enforce an automatic moratorium on the right of patients to use new drugs; Introduction of user fees and levies in order to recover the bureaucratic costs associated with drug...

  • Canadian mail-order pharmacy in turmoil. Ukens, Carol // Drug Topics;2/7/2005, Vol. 149 Issue 3, p44 

    Canada Health Minister Ujjal Dosanjh made three regulatory proposals to protect the coutnry's domestic drug supply and pricing structure. Dosanjh has proposed making it illegal for Canadian doctors to co-sign foreign scripts, prohibiting noncitizens from acquiring drugs unless they come to...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics